Aging and neurodegeneration. Molecular mechanisms of neuronal loss in Huntington's disease

Mechanisms of Ageing and Development

Volumn 127, Issue 5, 2006, Pages 432-435

  Lee, Soon Tae ^a   Kim, Manho ^a  

^a Seoul National University Hospital   (South Korea)

Author keywords

Caspase; Huntington's disease; Neurodegeneration; Protein aggregation

Indexed keywords

CASPASE; CREATINE; HUNTINGTIN; MINOCYCLINE; NEUROTRANSMITTER; POLYGLUTAMINE; RILUZOLE; TAUROURSODEOXYCHOLIC ACID;

AGING; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; HUMAN; HUNTINGTON CHOREA; NERVE DEGENERATION; NEUROPROTECTION; ONSET AGE; PRIORITY JOURNAL; PROTEIN AGGREGATION; STEM CELL TRANSPLANTATION; TOXICITY; TRINUCLEOTIDE REPEAT;

AGING; ANIMALS; CASPASES; ENZYME ACTIVATION; HUMANS; HUNTINGTON DISEASE; NERVE DEGENERATION; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; NUCLEAR PROTEINS;

EID: 33646492607     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mad.2006.01.022     Document Type: Article

References (37)

1. Armstrong R.J., Watts C., Svendsen C.N., Dunnett S.B., and Rosser A.E. Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease. Cell Transplant 9 (2000) 55-64
2. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
3. Bachoud-Levi A.C., Remy P., Nguyen J.P., Brugieres P., Lefaucheur J.P., Bourdet C., et al. Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356 (2000) 1975-1979
4. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555
5. Bonelli R.M., Hodl A.K., Hofmann P., and Kapfhammer H.P. Neuroprotection in Huntington's disease: a 2-year study on minocycline. Int. Clin. Psychopharmacol. 19 (2004) 337-342
6. Browne S.E., and Beal M.F. The energetics of Huntington's disease. Neurochem. Res. 29 (2004) 531-546
7. Cha J.H., Kosinski C.M., Kerner J.A., et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 6480-6485
8. Chen M., Ona V.O., Li M., Ferrante R.J., Fink K.B., Zhu S., Bian J., Guo L., Farrell L.A., Hersch S.M., Hobbs W., Vonsattel J.P., Cha J.H., and Friedlander R.M. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat. Med. 6 (2000) 797-801
9. Chen S., Berthelier V., Yang W., and Wetzel R. Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311 (2001) 173-182
10. Chen G.J., Jeng C.H., Lin S.Z., Tsai S.H., Wang Y., and Chiang Y.H. Fetal striatal transplants restore electrophysiological sensitivity to dopamine in the lesioned striatum of rats with experimental Huntington's disease. J. Biomed. Sci. 9 (2002) 303-310
11. Chopp M., and Li Y. Treatment of neural injury with marrow stromal cells. Lancet Neurol. 1 (2002) 92-100
12. Davidson B.L., and Paulson H.L. Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet Neurol. 3 (2004) 145-149
13. Gaura V., Bachoud-Levi A.C., Ribeiro M.J., Nguyen J.P., Frouin V., Baudic S., et al. Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 127 (2004) 65-72
14. Hantraye P., Riche D., Maziere M., and Isacson O. Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4187-4191
15. Hauser R.A., Furtado S., Cimino C.R., Delgado H., Eichler S., Schwartz S., et al. Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58 (2002) 687-695
16. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on HD chromosomes. Cell 72 (1993) 971-983
17. Hurelbrink C.B., Armstrong R.J., Barker R.A., Dunnett S.B., and Rosser A.E. Hibernated human fetal striatal tissue: successful transplantation in a rat model of Huntington's disease. Cell Transplant 9 (2000) 743-749
18. Keene C.D., Rodrigues C.M., Eich T., Chhabra M.S., Steer C.J., and Low W.C. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 10671-10676
19. Kiechle T., Dedeoglu A., Kubilus J., et al. Cytochrome c and caspase-9 expression in Huntington's disease. Neuromol. Med. 1 (2002) 183-195
20. Kremer B., Goldberg P., Andrew S.E., Theilmann J., Telenius H., Zeisler J., Squitieri F., Lin B., Bassett A., Almqvist E., et al. A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N. Engl. J. Med. 330 (1994) 1401-1406
21. Kuemmerle S., et al. Huntington aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46 (1999) 842-849
22. Lescaudron L., Unni D., and Dunbar G.L. Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes. Int. J. Neurosci. 113 (2003) 945-956
23. Li S.H., Lam S., Cheng A.L., and Li X.J. Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis. Hum. Mol. Genet. 9 (2000) 2859-2867
24. Lindvall O., Kokaia Z., and Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10 (2004) S42-S50
25. McBride J.L., Behrstock S.P., Chen E.Y., Jakel R.J., Siegel I., Svendsen C.N., and Kordower J.H. Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J. Comp. Neurol. 475 (2004) 211-219
26. Nucifora Jr. F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., and Ross C.A. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291 (2001) 2423-2428
27. Ona V.O., Li M., Vonsattel J.P., Andrews L.J., Khan S.Q., Chung W.M., Frey A.S., Menon A.S., Li X.J., Stieg P.E., Yuan J., Penney J.B., Young A.B., Cha J.H., and Friedlander R.M. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399 (1999) 263-267
28. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 10 (2004) S10-S17
29. Ryu J.K., Kim J., Cho S.J., Hatori K., Nagai A., Choi H.B., Lee M.C., McLarnon J.G., and Kim S.U. Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol. Dis. 16 (2004) 68-77
30. Sanchez I., Xu C.J., Juo P., Kakizaka A., Blenis J., and Yuan J. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22 (1999) 623-633
31. Sanchez I., Mahlke C., and Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421 (2003) 373-379
32. Sanchez I., Mahlke C., and Yuan J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421 (2003) 373-379
33. Scherzinger E., et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4604-4609
34. Seppi K., Mueller J., Bodner T., Brandauer E., Benke T., Weirich-Schwaiger H., Poewe W., and Wenning G.K. Riluzole in Huntington's disease (HD): an open label study with one year follow up. J. Neurol. 248 (2001) 866-869
35. Verbessem P., Lemiere J., Eijnde B.O., Swinnen S., Vanhees L., Van Leemputte M., Hespel P., and Dom R. Creatine supplementation in Huntington's disease: a placebo-controlled pilot trial. Neurology 61 (2003) 925-930
36. Vonsattel J.P., Myers R.H., Stevens T.J., Ferrante R.J., Bird E.D., and Richardson Jr. E.P. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44 (1985) 559-577
37. Wellington C.L., Ellerby L.M., Hackam A.S., et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273 (1998) 9158-9167